Australian Clinical Labs Ltd
ASX:ACL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Australian Clinical Labs Ltd
Australian Clinical Labs Ltd
Current Portion of Long-Term Debt
Australian Clinical Labs Ltd
Current Portion of Long-Term Debt Peer Comparison
HLA
SHL
IDX
CAJ
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Current Portion of Long-Term Debt
AU$101.1m
|
CAGR 3-Years
17%
|
CAGR 5-Years
139%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Current Portion of Long-Term Debt
AU$19.2m
|
CAGR 3-Years
39%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Current Portion of Long-Term Debt
AU$800.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
356%
|
CAGR 10-Years
4%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Current Portion of Long-Term Debt
AU$17.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Current Portion of Long-Term Debt
AU$10.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
|
H
|
Healius Ltd
ASX:HLS
|
Current Portion of Long-Term Debt
AU$263.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
238%
|
CAGR 10-Years
55%
|
See Also
What is Australian Clinical Labs Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
101.1m
AUD
Based on the financial report for Jun 30, 2023, Australian Clinical Labs Ltd's Current Portion of Long-Term Debt amounts to 101.1m AUD.
What is Australian Clinical Labs Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
139%
Over the last year, the Current Portion of Long-Term Debt growth was 7%. The average annual Current Portion of Long-Term Debt growth rates for Australian Clinical Labs Ltd have been 17% over the past three years , 139% over the past five years .
You don't have any saved screeners yet
